Mesenchymal stem cells derived from the placenta and its secretions in the treatment of graft versus host disease

Phase 3

Recruiting

• Conditions: Graft versus host disease.; Graft-versus-host disease; D89.81

• Registration Number: IRCT20201108049311N7
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients with acute GVHD with fever and requiring hospitalization

Exclusion Criteria

Patients with sepsis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Skin rash. Timepoint: At the beginning of the study and 6 weeks after the intervention. Method of measurement: Examination of appearance (shape, color and texture of skin rash), determination of BSA percentage and staging based on it.;Liver involvement. Timepoint: At the beginning of the study and 6 weeks after the intervention. Method of measurement: Measurement of Bilirubin level.;Intestine condition. Timepoint: At the beginning of the study and 6 weeks after the intervention. Method of measurement: Diarrhea volume measurement.